Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
复制标题
DOI：
10.1016/j.dsx.2020.04.001
复制
发表时间：
2020-07-01
影响因子：
10
通讯作者：
Misra, Anoop
中科院分区：
文献类型：
--
作者：
Ghosh, Amerta;Gupta, Ritesh;Misra, Anoop
背景和目的：鉴于新冠肺炎疫情对患者行动能力的限制，面对面的会诊很困难。方法：应用计算机检索PubMed和谷歌学者数据库，检索词为“远程医疗”、“糖尿病”、“新冠肺炎”，检索词为“远程医疗”、“糖尿病”、“新冠肺炎”。结果：我们讨论了远程医疗在糖尿病患者中作用的证据和一般指南，以及它的实用性和局限性。结论：远程医疗是一种有用的工具，可以在这一禁闭期内管理糖尿病患者。然而，数据有限，还需要进一步的研究。(C)2020年，由爱思唯尔有限公司代表印度糖尿病出版。
Background and aims: In view of restrictions on mobility of patients because of COVID-19 pandemic, faceto-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.Methods: PubMed and Google Scholar search engines were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19 up to 31st March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed.Results: We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.Conclusions: Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required. (C) 2020 Published by Elsevier Ltd on behalf of Diabetes India.